Schedule of Investments (unaudited)	iShares®  MSCI Switzerland ETF
November 30, 2021	(Percentages shown are based on Net Assets)

Security	Shares		Value
Common Stocks
Building Products — 1.8%
Geberit AG, Registered		38,370	$	29,295,912
Capital Markets — 8.3%
Credit Suisse Group AG, Registered		2,551,129		24,632,176
Julius Baer Group Ltd.		254,848		15,816,882
Partners Group Holding AG		20,066		34,630,857
UBS Group AG, Registered		3,572,695		61,777,164
				136,857,079
Chemicals — 7.2%
Clariant AG, Registered		303,219		5,937,475
EMS-Chemie Holding AG, Registered		9,731		9,276,521
Givaudan SA, Registered		9,535		46,614,216
Sika AG, Registered		144,798		56,543,752
				118,371,964
Construction Materials — 1.6%
Holcim Ltd		552,022		26,593,033
Diversified Telecommunication Services — 1.0%
Swisscom AG, Registered		29,764		16,534,220
Electrical Equipment — 3.5%
ABB Ltd., Registered		1,674,105		57,895,216
Food Products — 22.7%
Barry Callebaut AG, Registered		4,577		10,828,377
Chocoladefabriken Lindt & Spruengli AG, Participation
Certificates, NVS		1,256		15,473,406
Chocoladefabriken Lindt & Spruengli AG, Registered		123		15,193,290
Nestle SA, Registered		2,606,632		334,096,559
				375,591,632
Health Care Equipment & Supplies — 5.3%
Alcon Inc.		511,329		40,389,217
Sonova Holding AG, Registered		60,250		22,643,060
Straumann Holding AG, Registered		11,346		24,120,998
				87,153,275
Insurance — 7.2%
Baloise Holding AG, Registered		58,656		8,750,282
Swiss Life Holding AG, Registered		34,433		19,762,479
Swiss Re AG		303,496		28,486,297
Zurich Insurance Group AG		152,243		62,588,542
				119,587,600
Life Sciences Tools & Services — 3.9%
Bachem Holding AG, Class B, Registered		4,075		2,947,334
Lonza Group AG, Registered		75,833		61,147,744
				64,095,078
Machinery — 1.4%
Schindler Holding AG, Participation Certificates, NVS		48,040		12,373,569
Schindler Holding AG, Registered		28,041		6,959,541
VAT Group AG(a)		9,427		4,548,947
				23,882,057

Security	Shares		Value
Marine — 1.1%
Kuehne + Nagel International AG, Registered		61,643	$	17,621,813
Pharmaceuticals — 25.0%
Novartis AG, Registered		1,919,021		152,956,986
Roche Holding AG, NVS.		639,617		249,712,970
Roche Holding AG, Bearer		7,383		3,061,334
Vifor Pharma AG		62,103		6,962,333
				412,693,623
Professional Services — 1.7%
Adecco Group AG, Registered		187,321		8,681,083
SGS SA, Registered		6,656		20,079,627
				28,760,710
Real Estate Management & Development — 0.6%
Swiss Prime Site AG, Registered		98,484		9,328,963
Software — 0.6%
Temenos AG, Registered		84,343		10,786,989
Technology Hardware, Storage & Peripherals — 0.9%
Logitech International SA, Registered		180,106		14,364,135
Textiles, Apparel & Luxury Goods — 5.5%
Cie. Financiere Richemont SA, Class A, Registered		498,680		74,211,292
Swatch Group AG (The), Bearer		36,105		10,604,380
Swatch Group AG (The), Registered		92,215		5,266,265
				90,081,937
Total Common Stocks — 99.3%
(Cost: $1,385,549,374)				1,639,495,236

Short-Term Investments

Money Market Funds — 0.0%
BlackRock Cash Funds: Treasury, SL Agency Shares,
0.00%(b)(c)	840,000		840,000
Total Short-Term Investments — 0.0%
(Cost: $840,000)			840,000
Total Investments in Securities — 99.3%
(Cost: $1,386,389,374)			1,640,335,236
Other Assets, Less Liabilities — 0.7%			11,161,120
Net Assets — 100.0%		$	1,651,496,356

^(a) Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

^(b) Affiliate of the Fund.

^(c) Annualized 7-day yield as of period end.

1

Schedule of Investments (unaudited) (continued)	iShares®  MSCI Switzerland ETF
November 30, 2021

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the period ended November 30, 2021 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

Affiliated Issuer	Value at 08/31/21		Purchases at Cost			Proceeds from Sales		Net Realized Gain (Loss)		Change in Unrealized Appreciation (Depreciation)		Value at 11/30/21		Shares Held at 11/30/21		Income		Capital Gain Distributions from Underlying Funds
BlackRock Cash Funds: Treasury, SL Agency Shares	$	730,000	$	110,000	(a)	$	—	$	—	$	110,000	$	840,000		840,000	$	8	$	—

^(a) Represents net amount purchased (sold).

Derivative Financial Instruments Outstanding as of Period End

Futures Contracts

							Value/
					Notional		Unrealized
	Number of		Expiration		Amount		Appreciation
Description	Contracts		Date		(000)		(Depreciation)
Long Contracts
Swiss Market Index		89		12/17/21	$	11,793	$	190,584

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

• Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

• Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs); and

• Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the BlackRock Global Valuation Methodologies Committee’s (the “Global Valuation Committee’s”) assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Global Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds. There may not be a secondary market, and/or there are a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Fund’s policy regarding valuation of financial instruments, refer to its most recent financial statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

	Level 1		Level 2		Level 3		Total
Investments
Assets
Common Stocks	$	30,666,696	$	1,608,828,540	$	—	$	1,639,495,236
Money Market Funds		840,000		—		—		840,000
	$	31,506,696	$	1,608,828,540	$	—	$	1,640,335,236
Derivative financial instruments(a)
Assets
Futures Contracts	$	—	$	190,584	$	—	$	190,584

^(a) Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

2

Schedule of Investments (unaudited) (continued)	iShares®  MSCI Switzerland ETF
November 30, 2021

Portfolio Abbreviations - Equity

NVS Non-Voting Shares

3